A phase I study of nivolumab (anti-PD-1; BMS-936558, ONO-4538) plus platinum-based doublet chemotherapy (PT-doublet) in chemotherapy-naive non-small cell lung cancer (NSCLC) patients (pts) Meeting Abstract
| Authors: | Rizvi, N. A.; Antonia, S. J.; Man Chow, L. Q.; Brahmer, J. R.; Juergens, R. A.; Borghaei, H.; Shepherd, F. A.; Laurie, S. A.; Gerber, D. E.; Wade Goldman, J.; Shen, Y.; Harbison, C.; Alaparthy, S.; Chen, A. C.; Gettinger, S. N. |
| Abstract Title: | A phase I study of nivolumab (anti-PD-1; BMS-936558, ONO-4538) plus platinum-based doublet chemotherapy (PT-doublet) in chemotherapy-naive non-small cell lung cancer (NSCLC) patients (pts) |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419602552 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.8072 |
| Notes: | Meeting Abstract: 8072 -- Source: Wos |
